Related Experiment Video

Updated: Jun 1, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

RUNX3 functions as an oncogene in ovarian cancer

Cecilia Wei Lin Lee1, Linda Shyue Huey Chuang, Shunichi Kimura

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore.

Gynecologic Oncology
|May 27, 2011
PubMed
Abstract

Insights

RUNX3 acts as an oncogene in ovarian cancer, promoting cell growth. Its nuclear expression in ovarian cancer cells indicates a potential therapeutic target for this disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • RUNX3 (Runt domain transcription factor 3) exhibits context-dependent roles in cancer, acting as a tumor suppressor in some cancers and an oncogene in others.
  • Previous studies have indicated both tumor-suppressive and oncogenic functions for RUNX3 across various cancer types.

Purpose of the Study:

  • To investigate the specific role of RUNX3 in the development and progression of ovarian cancer.
  • To determine if RUNX3 acts as a tumor suppressor or oncogene in ovarian cancer.

Main Methods:

  • Assessed RUNX3 mRNA and protein expression in ovarian cancer cell lines and tissues.
  • Examined the subcellular localization of RUNX3.
  • Investigated the impact of RUNX3 modulation (expression and knockdown) on ovarian cancer cell proliferation using proliferation assays and soft agar assays.

Main Results:

  • RUNX3 was detected in the nucleus of ovarian cancer cell lines and tissues, suggesting nuclear localization is important for its function.
  • RUNX3 knockdown significantly decreased ovarian cancer cell proliferation in both liquid culture and soft agar assays.
  • Exogenous expression of RUNX3 promoted cell growth in ovarian cancer cell lines that did not initially express RUNX3, contrasting its known tumor-suppressive role in other cell types.

Conclusions:

  • RUNX3 is frequently expressed in the nucleus of ovarian cancer cells.
  • RUNX3 plays a significant oncogenic role in ovarian cancer, promoting tumor cell proliferation.

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...